Bringing the fundamentals into focus…
Back to Ionis Pharmaceuticals, Inc.
How Ionis Pharmaceuticals, Inc. stacks up
IONS · against 189 other Healthcare companies of similar size
Growth
30/ 100
Near the bottom of its peers.
Ranked #157 of 190 · scores higher than 17% of peers
Bars: peers in each 10-point band of the growth score24 peers with a growth score of 30–39, including IONS · Click a bar to see the companies
Why growth scores 30?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings per share growth and revenue growth, which are weaker than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- slower revenue growth over the last year: weaker than 82% of peers. Revenue growth: -7.4% vs peer median 6.1%
- faster revenue growth over three years: stronger than 66% of peers. 3-year revenue growth: 11.5% vs peer median 5.8%
Metric by metric
Position: dot = IONS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IONS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 190 reported | -7.4% | 8.5% | 11% | 33% | |
| Earnings per share growthHigher is better · 132 reported | Not reported | 9.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 183 reported | 11.5% | 9.3% | 61% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around IONS| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.8B USD | 99 | 31 | |
| 3 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 3 | 3.8B USD | 98 | 71 | |
| 3 | 9.3B USD | 98 | 64 | |
| 151 | 12.3B USD | 33 | 35 | |
| 154 | 52.2B HKD (≈$6.7B) | 32 | 56 | |
| 155 | 70.9B ZAR (≈$3.9B) | 31 | 48 | |
| 155 | 10.8B USD | 31 | 35 | |
| 157 | 6.7B USD | 30 | 19 | |
| 158 | 8.6B USD | 28 | 30 | |
| 158 | 11.9B USD | 28 | 53 | |
| 160 | 12.7B AUD (≈$8.4B) | 27 | 38 | |
| 160 | 3.2B EUR (≈$3.6B) | 27 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score